A study to assess the effect of fluvoxamine and smoking on pharmacokinetics ( the movement of drugs within the body) of AZD4635 in healthy volunteers

Trial Identifier: D8730C00007
Sponsor: AstraZeneca
Parexel International
NCTID:: NCT04478513
Start Date: July 2020
Primary Completion Date: December 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
United Kingdom Harrow, United Kingdom, HA1 3UJ